These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37442729)

  • 1. Antimicrobial Properties of Equine Stromal Cells and Platelets and Future Directions.
    Pezzanite LM; Chow L; Dow SW; Goodrich LR; Gilbertie JM; Schnabel LV
    Vet Clin North Am Equine Pract; 2023 Dec; 39(3):565-578. PubMed ID: 37442729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One health in regenerative medicine: report on the second Havemeyer symposium on regenerative medicine in horses.
    Fortier LA; Goodrich LR; Ribitsch I; Schnabel LV; Shepard DO; Van de Walle GR; Watts AE; Whealands Smith RK
    Regen Med; 2020 Jun; 15(6):1775-1787. PubMed ID: 32808582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell therapy in horses: useful beyond orthopedic injuries?
    De Schauwer C; Van de Walle GR; Van Soom A; Meyer E
    Vet Q; 2013 Dec; 33(4):234-41. PubMed ID: 23697553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to Equine Biologic and Regenerative Therapies.
    Boone L; Peroni J
    Vet Clin North Am Equine Pract; 2023 Dec; 39(3):419-427. PubMed ID: 37558508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based therapies: current issues and future directions.
    Stewart MC
    Vet Clin North Am Equine Pract; 2011 Aug; 27(2):393-9. PubMed ID: 21872767
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Avellar HK; Lutter JD; Ganta CK; Beard W; Smith JR; Jonnalagadda N; Peloquin S; Kang Q; Ayub K
    Can J Vet Res; 2022 Jan; 86(1):59-64. PubMed ID: 34975224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future regenerative medicine - principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine.
    Koch TG; Berg LC; Betts DH
    Can Vet J; 2009 Feb; 50(2):155-65. PubMed ID: 19412395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine Platelet-Rich Plasma.
    McCarrel TM
    Vet Clin North Am Equine Pract; 2023 Dec; 39(3):429-442. PubMed ID: 37550126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine platelet lysate as an alternative to fetal bovine serum in equine mesenchymal stromal cell culture - too much of a good thing?
    Russell KA; Koch TG
    Equine Vet J; 2016 Mar; 48(2):261-4. PubMed ID: 25772755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Stem Cells for the Treatment of Musculoskeletal Injuries in Horses.
    Watts AE
    Vet Clin North Am Equine Pract; 2023 Dec; 39(3):475-487. PubMed ID: 37625917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cell-secreted CCL2 promotes antibacterial defense mechanisms through increased antimicrobial peptide expression in keratinocytes.
    Marx C; Gardner S; Harman RM; Wagner B; Van de Walle GR
    Stem Cells Transl Med; 2021 Dec; 10(12):1666-1679. PubMed ID: 34528765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Equine Stem Cells: Sources, Practices, and Potential Safety Concerns.
    Koch TG; Kuzma-Hunt AG; Russell KA
    Vet Clin North Am Equine Pract; 2023 Dec; 39(3):461-474. PubMed ID: 37574382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mesenchymal stromal cell secretome impairs methicillin-resistant Staphylococcus aureus biofilms via cysteine protease activity in the equine model.
    Marx C; Gardner S; Harman RM; Van de Walle GR
    Stem Cells Transl Med; 2020 Jul; 9(7):746-757. PubMed ID: 32216094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse.
    Barrachina L; Romero A; Zaragoza P; Rodellar C; Vázquez FJ
    Vet J; 2018 Aug; 238():49-57. PubMed ID: 30103915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial peptides secreted by equine mesenchymal stromal cells inhibit the growth of bacteria commonly found in skin wounds.
    Harman RM; Yang S; He MK; Van de Walle GR
    Stem Cell Res Ther; 2017 Jul; 8(1):157. PubMed ID: 28676123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease.
    Borjesson DL; Peroni JF
    Clin Lab Med; 2011 Mar; 31(1):109-23. PubMed ID: 21295725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous Platelet Lysate Does Not Enhance Chondrogenic Differentiation of Equine Bone Marrow-Derived Mesenchymal Stromal Cells Despite Increased TGF-β1 Concentration.
    Chapman HS; Gale AL; Dodson ME; Linardi RL; Ortved KF
    Stem Cells Dev; 2020 Feb; 29(3):144-155. PubMed ID: 31802705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine cellular therapy--from stall to bench to bedside?
    Burk J; Badylak SF; Kelly J; Brehm W
    Cytometry A; 2013 Jan; 83(1):103-13. PubMed ID: 23081833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow mesenchymal stromal cells for regeneration of injured equine ligaments and tendons: a clinical report.
    Renzi S; Riccò S; Dotti S; Sesso L; Grolli S; Cornali M; Carlin S; Patruno M; Cinotti S; Ferrari M
    Res Vet Sci; 2013 Aug; 95(1):272-7. PubMed ID: 23419936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant
    Pezzanite LM; Chow L; Phillips J; Griffenhagen GM; Moore AR; Schaer TP; Engiles JB; Werpy N; Gilbertie J; Schnabel LV; Antczak D; Miller D; Dow S; Goodrich LR
    Ann Transl Med; 2022 Nov; 10(21):1157. PubMed ID: 36467344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.